ATYR
aTyr Pharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website atyrpharma.com
- Employees(FY) 56
- ISIN US0021202025
Performance
-0.53%
1W
-0.0%
1M
+3.3%
3M
+12.57%
6M
+33.33%
YTD
+13.94%
1Y
Profile
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Technical Analysis of ATYR 2024-09-06
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-08-20 20:00
aTyr Pharma to Participate in September Investor Conferences(Globenewswire)
- 2024-08-13 04:00
- 2024-08-05 20:00
- 2024-07-29 20:00
aTyr Pharma Announces Research Study with Stanford Medicine(Globenewswire)
- 2024-07-21 20:00
- 2024-06-17 21:40
- 2024-06-09 22:52
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2023(Investorplace)
- 2024-06-05 03:17
- 2024-06-02 20:00
- 2024-05-24 04:00
- 2024-05-14 19:00
- 2024-05-13 20:00
- 2024-05-05 20:00
aTyr Pharma to Present at Upcoming Investor Conferences(Globenewswire)
- 2024-05-02 09:58
- 2024-05-02 04:15
Atyr Pharma: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-02 04:00
- 2024-03-31 20:00
aTyr Pharma to Participate in April Investor Conferences(Globenewswire)
- 2024-03-26 02:19
- 2024-03-15 01:33
- 2024-03-14 23:30
Q4 2023 aTyr Pharma Inc Earnings Call(Yahoo Finance)
- 2024-03-14 23:01
- 2024-03-14 08:56
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023(Investorplace)
- 2024-03-14 04:16
Atyr Pharma: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-14 04:00
- 2024-02-27 19:00
- 2024-02-20 19:00
- 2024-01-28 19:00
- 2024-01-17 19:00
- 2023-11-12 19:00
- 2023-11-09 03:07
Atyr Pharma: Q3 Earnings Snapshot(Yahoo Finance)
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.